Vera Therapeutics Inc expected to post a loss of 56 cents a share - Earnings Preview

Vera Therapeutics

06/08/2024 17:14

* Vera Therapeutics Inc  VERA.OQ   VERA.O  is expected
to show no
change in quarterly revenue when it reports  results on August 8
(estimated) for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for Vera Therapeutics Inc is
for a
loss of 56 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Vera
Therapeutics
Inc is $56.00​, above​ its last closing price of $36.00. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   -0.54       -0.53      -0.56     Missed  -5.7
 Dec. 31 0001  -0.53       -0.51      -0.60     Missed  -18.2
 Sep. 30 2023  -0.53       -0.53      -0.45     Beat    15.6​
 Jun. 30 2023  -0.70       -0.69      -0.46     Beat    33.7
 ​​Mar.        -0.60       -0.60      -0.80     Missed  -32.4
 31 2023                                                
 Dec. 31 2022              -0.90      -1.18     Missed  -30.6​
 Sep. 30 2022  -0.67       -0.72      -0.91     Missed  -26.1
 Jun. 30 2022  -0.72       -0.72      -0.55     Beat    23.4
 This summary was machine generated August 6 at 16:14 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)